- Home
- CANF vs IPW Comparison
CANF vs IPW Comparison
Compare CANF & IPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANF
- IPW
- Stock Information
- Founded
- CANF 1994
- IPW 2018
- Country
- CANF Israel
- IPW United States
- Employees
- CANF N/A
- IPW N/A
- Industry
- CANF Biotechnology: Pharmaceutical Preparations
- IPW Catalog/Specialty Distribution
- Sector
- CANF Health Care
- IPW Consumer Discretionary
- Exchange
- CANF Nasdaq
- IPW Nasdaq
- Market Cap
- CANF 14.8M
- IPW 17.1M
- IPO Year
- CANF N/A
- IPW 2021
- Fundamental
- Price
- CANF $1.05
- IPW $0.63
- Analyst Decision
- CANF Strong Buy
- IPW Strong Buy
- Analyst Count
- CANF 2
- IPW 1
- Target Price
- CANF $14.00
- IPW $2.75
- AVG Volume (30 Days)
- CANF 172.6K
- IPW 32.7K
- Earning Date
- CANF 05-27-2025
- IPW 05-15-2025
- Dividend Yield
- CANF N/A
- IPW N/A
- EPS Growth
- CANF N/A
- IPW N/A
- EPS
- CANF N/A
- IPW N/A
- Revenue
- CANF $674,000.00
- IPW $80,844,081.00
- Revenue This Year
- CANF $461.72
- IPW $8.31
- Revenue Next Year
- CANF N/A
- IPW $77.15
- P/E Ratio
- CANF N/A
- IPW N/A
- Revenue Growth
- CANF N/A
- IPW N/A
- 52 Week Low
- CANF $1.02
- IPW $0.41
- 52 Week High
- CANF $4.69
- IPW $3.65
- Technical
- Relative Strength Index (RSI)
- CANF 37.30
- IPW 61.94
- Support Level
- CANF $0.98
- IPW $0.52
- Resistance Level
- CANF $1.14
- IPW $0.65
- Average True Range (ATR)
- CANF 0.06
- IPW 0.05
- MACD
- CANF 0.01
- IPW 0.01
- Stochastic Oscillator
- CANF 32.59
- IPW 99.23
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.